{"id":"https://openalex.org/W59623194","doi":null,"title":"Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone.","display_name":"Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone.","publication_year":1996,"publication_date":"1996-01-01","ids":{"openalex":"https://openalex.org/W59623194","mag":"59623194","pmid":"https://pubmed.ncbi.nlm.nih.gov/9028057"},"language":"en","primary_location":{"id":"pmid:9028057","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9028057","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annali dell'Istituto superiore di sanita","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074163664","display_name":"Renato Scifo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Scifo","raw_affiliation_strings":["Servizio di Psichiatria, Istituto OASI per lo Studio del Ritardo Mentale e l'Involuzione Cerebrale, Troina (Enna), Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servizio di Psichiatria, Istituto OASI per lo Studio del Ritardo Mentale e l'Involuzione Cerebrale, Troina (Enna), Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022605924","display_name":"Matteo Cioni","orcid":"https://orcid.org/0000-0002-7594-6939","observed_orcids":["https://orcid.org/0000-0002-7594-6939"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Cioni","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113577689","display_name":"Alfredo Nicolosi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Nicolosi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062858826","display_name":"Nunzio Batticane","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Batticane","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075407827","display_name":"Cataldo Tirolo","orcid":"https://orcid.org/0000-0003-1747-8134","observed_orcids":["https://orcid.org/0000-0003-1747-8134"]},"institutions":[{"id":"https://openalex.org/I4210090132","display_name":"Oasi Maria SS","ror":"https://ror.org/00dqmaq38","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210090132","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"C Tirolo","raw_affiliation_strings":["Associazione Oasi Maria SS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Associazione Oasi Maria SS","institution_ids":["https://openalex.org/I4210090132"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001302471","display_name":"Nunzio Testa","orcid":"https://orcid.org/0000-0002-4024-2325","observed_orcids":["https://orcid.org/0000-0002-4024-2325"]},"institutions":[{"id":"https://openalex.org/I4210090132","display_name":"Oasi Maria SS","ror":"https://ror.org/00dqmaq38","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210090132","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"N Testa","raw_affiliation_strings":["Associazione Oasi Maria SS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Associazione Oasi Maria SS","institution_ids":["https://openalex.org/I4210090132"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039060959","display_name":"Maria Catena Ausilia Quattropani","orcid":"https://orcid.org/0000-0003-0711-6412","observed_orcids":["https://orcid.org/0000-0003-0711-6412"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M C Quattropani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013252840","display_name":"Maria C. Morale","orcid":"https://orcid.org/0000-0003-0624-7234","observed_orcids":["https://orcid.org/0000-0003-0624-7234"]},"institutions":[{"id":"https://openalex.org/I4210090132","display_name":"Oasi Maria SS","ror":"https://ror.org/00dqmaq38","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210090132","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"M C Morale","raw_affiliation_strings":["Associazione Oasi Maria SS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Associazione Oasi Maria SS","institution_ids":["https://openalex.org/I4210090132"]}]},{"author_position":"middle","author":{"id":null,"display_name":"F Gallo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I39063666","display_name":"University of Catania","ror":"https://ror.org/03a64bh57","country_code":"IT","type":"education","lineage":["https://openalex.org/I39063666"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"F Gallo","raw_affiliation_strings":["University of Catania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Catania","institution_ids":["https://openalex.org/I39063666"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020938978","display_name":"Bianca Marchetti","orcid":"https://orcid.org/0000-0002-9287-8448","observed_orcids":["https://orcid.org/0000-0002-9287-8448"]},"institutions":[{"id":"https://openalex.org/I4210090132","display_name":"Oasi Maria SS","ror":"https://ror.org/00dqmaq38","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210090132","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"B Marchetti","raw_affiliation_strings":["Associazione Oasi Maria SS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Associazione Oasi Maria SS","institution_ids":["https://openalex.org/I4210090132"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4153,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.55589917,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"32","issue":"3","first_page":"351","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10106","display_name":"Autism Spectrum Disorder Research","score":0.9657999873161316,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10106","display_name":"Autism Spectrum Disorder Research","score":0.9657999873161316,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.011900000274181366,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11541","display_name":"Neuroendocrine regulation and behavior","score":0.008899999782443047,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/autism-spectrum-disorder","display_name":"autism spectrum disorder","score":0.9290000200271606},{"id":"https://openalex.org/keywords/naltrexone","display_name":"naltrexone","score":0.8970000147819519},{"id":"https://openalex.org/keywords/neuroimmune-axis","display_name":"neuroimmune axis","score":0.8090000152587891},{"id":"https://openalex.org/keywords/opioid-antagonists","display_name":"opioid antagonists","score":0.7649999856948853},{"id":"https://openalex.org/keywords/lymphocyte-subsets","display_name":"lymphocyte subsets","score":0.7239999771118164},{"id":"https://openalex.org/keywords/cd4-cd8-ratio","display_name":"CD4/CD8 ratio","score":0.9909999966621399},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.9850000143051147},{"id":"https://openalex.org/keywords/beta-endorphin","display_name":"beta-endorphin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/behavioural-symptoms","display_name":"behavioural symptoms","score":0.5040000081062317},{"id":"https://openalex.org/keywords/immunological-screening","display_name":"immunological screening","score":0.6510000228881836}],"concepts":[{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.874465823173523},{"id":"https://openalex.org/C205778803","wikidata":"https://www.wikidata.org/wiki/Q38404","display_name":"Autism","level":2,"score":0.6491497159004211},{"id":"https://openalex.org/C2778140631","wikidata":"https://www.wikidata.org/wiki/Q2026938","display_name":"Opiate","level":3,"score":0.5713039636611938},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5171248912811279},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5163875222206116},{"id":"https://openalex.org/C88016717","wikidata":"https://www.wikidata.org/wiki/Q417189","display_name":"Opioid peptide","level":4,"score":0.49245724081993103},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.4513470530509949},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44869542121887207},{"id":"https://openalex.org/C2775962371","wikidata":"https://www.wikidata.org/wiki/Q908096","display_name":"Opioid antagonist","level":5,"score":0.42621082067489624},{"id":"https://openalex.org/C2777803847","wikidata":"https://www.wikidata.org/wiki/Q325101","display_name":"Enkephalin","level":4,"score":0.4221000671386719},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.4110940098762512},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.3738921284675598},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34825432300567627},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33722764253616333},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2983306646347046},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.14453819394111633},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.08714640140533447},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001321","descriptor_name":"Autistic Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001321","descriptor_name":"Autistic Disorder","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D001321","descriptor_name":"Autistic Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D001519","descriptor_name":"Behavior","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001615","descriptor_name":"beta-Endorphin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015703","descriptor_name":"Antigens, CD","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016131","descriptor_name":"Lymphocyte Subsets","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:9028057","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9028057","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annali dell'Istituto superiore di sanita","raw_type":"Clinical Trial"},{"id":"mag:59623194","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9028057","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2194823843","https://openalex.org/W2972588849","https://openalex.org/W2016393365","https://openalex.org/W1491065182","https://openalex.org/W77775552","https://openalex.org/W2432796009","https://openalex.org/W2136581101","https://openalex.org/W2126320656","https://openalex.org/W2415795497","https://openalex.org/W2093418477"],"abstract_inverted_index":{"The":[0,82,112],"emerging":[1],"concept":[2],"of":[3,10,13,20,23,73,101,109,122,131,139,147,179],"opioid":[4],"peptides":[5],"as":[6],"a":[7,21,64,98,128,136,145],"new":[8],"class":[9],"chemical":[11],"messengers":[12],"the":[14,18,44,71,88,102,120,123,132,140,148,169,192],"neuroimmune":[15],"axis":[16],"and":[17,35,38,76,91,135,156,182],"presence":[19],"number":[22],"immunological":[24,185],"abnormalities":[25],"in":[26,105,119,144,152,176],"infantile":[27],"autism":[28],"prompted":[29],"us":[30],"to":[31,56,61,161],"correlate":[32],"biological":[33],"(hormonal":[34],"immunological)":[36],"determinations":[37],"behavioural":[39,83,113],"performances":[40],"during":[41],"treatment":[42,96],"with":[43,68,127,195],"potent":[45],"opiate":[46,196],"antagonist,":[47],"naltrexone":[48],"(NAL).":[49],"Twelve":[50],"autistic":[51,103,180],"patients":[52],"ranging":[53],"from":[54],"7":[55],"15":[57],"years,":[58],"diagnosed":[59],"according":[60],"DSM-III-R,":[62],"entered":[63],"double-blind":[65],"crossover":[66],"study":[67],"NAL":[69,95],"at":[70],"doses":[72],"0.5,":[74],"1.0":[75],"1.5":[77],"mg/kg":[78],"every":[79],"48":[80],"hours.":[81],"evaluation":[84],"was":[85,115],"conducted":[86],"using":[87],"specific":[89],"BSE":[90],"CARS":[92],"rating":[93],"scales":[94],"produced":[97],"significant":[99,129,137],"reduction":[100,138],"symptomatology":[104],"seven":[106],"(\"responders\")":[107],"out":[108],"12":[110],"children.":[111],"improvement":[114],"accompanied":[116],"by":[117],"alterations":[118],"distribution":[121],"major":[124],"lymphocyte":[125],"subsets,":[126],"increase":[130],"T-helper-inducers":[133],"(CD4+CD8-)":[134],"T-cytotoxic-suppressor":[141],"(CD4-CD8+)":[142],"resulting":[143],"normalization":[146],"CD4/CD8":[149],"ratio.":[150],"Changes":[151],"natural":[153],"killer":[154],"cells":[155],"activity":[157],"were":[158],"inversely":[159],"related":[160],"plasma":[162],"beta-endorphin":[163],"levels.":[164],"It":[165],"is":[166],"suggested":[167],"that":[168,183],"mechanisms":[170],"underlying":[171],"opioid-immune":[172],"interactions":[173],"are":[174],"altered":[175],"this":[177],"population":[178],"children":[181],"an":[184],"screening":[186],"may":[187],"have":[188],"prognostic":[189],"value":[190],"for":[191],"pharmacological":[193],"therapy":[194],"antagonists.":[197]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}